GSK to sue 3 domestic firms for Zofran business damages.

Published: 2004-03-23 07:00:00

Updated: 2004-03-23 07:00:00

The patent dispute on finasteride (a drug for the treatment of prostatomegaly), between Choongwe and MSD has not been smoothly solved but appealed to the Seoul High Court. Amid this atmosphere, GSK recently raised a lawsuit against 3 Korean companies for Zofran (ondansetron: anti-vomiting drug) ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK